As we mentioned on Tuesday, the majority of companies on the S&P 500 that have reported earnings, have beaten estimates, and ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

Once verified and submitted to the client ... the time spent dealing with such calls can be dramatically reduced. "GSK has confirmed that approximately 95 percent of its invoices delivered ...

Improving the customer onboarding experience in an increasingly competitive and congested financial services industry is vital for both legacy banks and those in fintech serious about growth... Guest ...

"On behalf of Vaxart and its Board, I would like to thank Bob for his years of service and contributions to our Company,” said Vaxart Board Chairman, Dr. Michael J. Finney.

Juno Corp. ("Juno" or the "Company"), a private Ontario exploration company and the largest mineral claimholder in the mineral-rich Ring of Fire in northern Ontario, is pleased to announce the highly ...

Boosting revenue through increased advertising, sweeping job cuts, and the ability to pay for a blue verified badge are ... including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly ...

KHC has received research funding from the National Institutes of Health, Merck, Exagen, Gilead, GSK, Eli Lilly, AstraZeneca ... XW and JAS directly accessed and verified the underlying data reported.

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

The University of Oxford and GSK are to work on a vaccine to target cells in the pre-cancerous stage (PA) Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to ...

Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...